Developing a pyroptosis-related gene signature to better predict the prognosis and immune status of patients with head and neck squamous cell carcinoma.
Developing a pyroptosis-related gene signature to better predict the prognosis and immune status of patients with head and neck squamous cell carcinoma.
复制标题
开发焦亡相关基因特征以更好地预测头颈鳞状细胞癌患者的预后和免疫状态
DOI:
10.3389/fgene.2022.988606
复制
发表时间:
2022
影响因子:
3.7
通讯作者:
Zhang, Su-Lin
中科院分区:
文献类型:
--
作者:
Liu, Dan;Zhou, Liu-Qing;Cheng, Qing;Wang, Jun;Kong, Wei-Jia;Zhang, Su-Lin
Chronic inflammation may promote the incidence and development of neoplasms. As a pro-inflammatory death pathway, pyroptosis could induce normal cells to transform into cancerous cells, but the potential effect of pyroptosis in head and neck squamous cell carcinoma (HNSCC) remains unclear. This study developed and evaluated a pyroptosis-related gene signature to predict the prognosis and immune status of patients with HNSCC. The gene expression, mutation information, and clinical characteristics of HNSCC were extracted from TCGA to establish a comprehensive genome database (GEO). Based on LASSO Cox regression model, nine pyroptosis-related genes (TTLL1, TRIML2, DYNC1I1, KLHL35, CAMK2N1, TNFRSF18, GLDC, SPINK5, and DKK1) were used to construct a pyroptosis-related gene signature, which had good ability to predict the prognosis of HNSCC. Furthermore, the expression of nine pyroptosis-related genes in HNSCC and paracancerous tissues was detected by quantitative real-time PCR (qRT-PCR). The potential immunotherapeutic features and drug sensitivity prediction of this signature were also explored. Because pyroptosis regulators play an important role in HNSCC development and prognoses, further exploration might assist in identifying new biomarkers and predictors of prognosis to benefit clinical identification and management.
登录
查看更多内容
DOI:
10.1186/s13046-021-01959-x
发表时间:
2021-05-03
期刊:
Journal of experimental & clinical cancer research : CR
影响因子:
--
作者:
Tan Y;Chen Q;Li X;Zeng Z;Xiong W;Li G;Li X;Yang J;Xiang B;Yi M
通讯作者:
Yi M
DOI:
10.1186/s13046-021-01995-7
发表时间:
2021-06-09
期刊:
Journal of experimental & clinical cancer research : CR
影响因子:
--
作者:
Cai J;Yi M;Tan Y;Li X;Li G;Zeng Z;Xiong W;Xiang B
通讯作者:
Xiang B
影响因子:
16.6
作者:
Chen C;He W;Huang J;Wang B;Li H;Cai Q;Su F;Bi J;Liu H;Zhang B;Jiang N;Zhong G;Zhao Y;Dong W;Lin T
通讯作者:
Lin T
影响因子:
37.3
作者:
Raj S;Kesari KK;Kumar A;Rathi B;Sharma A;Gupta PK;Jha SK;Jha NK;Slama P;Roychoudhury S;Kumar D
通讯作者:
Kumar D
影响因子:
4
作者:
Frank DN;Giese APJ;Hafren L;Bootpetch TC;Yarza TKL;Steritz MJ;Pedro M;Labra PJ;Daly KA;Tantoco MLC;Szeremeta W;Reyes-Quintos MRT;Ahankoob N;Llanes EGDV;Pine HS;Yousaf S;Ir D;Einarsdottir E;de la Cruz RAR;Lee NR;Nonato RMA;Robertson CE;Ong KMC;Magno JPM;Chiong ANE;Espiritu-Chiong MC;San Agustin ML;Cruz TLG;Abes GT;Bamshad MJ;Cutiongco-de la Paz EM;Kere J;Nickerson DA;Mohlke KL;Riazuddin S;Chan A;Mattila PS;Leal SM;Ryan AF;Ahmed ZM;Chonmaitree T;Sale MM;Chiong CM;Santos-Cortez RLP
通讯作者:
Santos-Cortez RLP